XBI 주가 전망 및 ETF 분석 - 배당·운용보수·보유종목·NAV·RSI·MACD

XBI

State Street SPDR S&P Biotech ETF

7월 28일 9:58 AM ET (한국 7/28 22:58)

$150.59

+0.11 ▲ +0.07%

XBI ETF is analyzed across 10 metrics including expense ratio, holdings, sector allocation, dividends, RSI, and MACD.

Total Expense Ratio

0.35%

Annual operating cost

Net Assets (AUM)

$10.0B

약 14조원

Holdings

157 items

Dividend Yield

0.38%

Management Style

Passive

Category ⓘ	US Equities - Industry Sector	Asset Type ⓘ	Equities (Stocks)	Return% 1Y ⓘ	71.35%	Total Holdings ⓘ	157	Perf Week ⓘ	-0.23%
ETF Type ⓘ	US Equities	Active/Passive ⓘ	Passive	Return% 3Y ⓘ	20.87%	AUM ⓘ	$10.0B	Perf Month ⓘ	-0.66%
Expense ⓘ	0.35%	NAV ⓘ	$150.56	Return% 5Y ⓘ	3.76%	52W High ⓘ	-9.12%	Perf Quarter ⓘ	12.99%
Dividend TTM ⓘ	$0.57 (0.38%)	Div Gr. 3/5Y ⓘ	- 9.6%	Return% 10Y ⓘ	10.52%	52W Low ⓘ	78.45%	Perf Half Y ⓘ	17.61%
Flows% 1M ⓘ	0.86%	Flows% YTD ⓘ	4.09%	Return% SI ⓘ	11.74%	Volatility(W/M) ⓘ	2.63% 2.69%	Perf YTD ⓘ	23.51%
SMA20 ⓘ	-3.73%	SMA50 ⓘ	4.65%	SMA200 ⓘ	17.5%	RSI (14) ⓘ	48.76	Beta ⓘ	0.83
IPO ⓘ	2006/2/6	Prev Close ⓘ	$150.48	Perf Year ⓘ	71.89%	Avg Volume ⓘ	9.01M	Price ⓘ	$150.59

📊 State Street SPDR S&P Biotech ETF (XBI) Investment Analysis

ETF Overview

State Street SPDR S&P Biotech ETF · US Equities - Industry Sector

헬스케어 섹터 — 헬스케어 섹터 ETF (제약·바이오·의료기기)

2006년 상장, 20년 운영 중.

SPDR S&P Biotech ETF는 수수료 및 비용 차감 전 기준으로 S&P Biotechnology Select Industry 지수의 총수익 성과를 추종하고자 합니다. 미국 전체 주식 시장 중 생공학(Biotechnology) 섹터 기업들의 성과를 측정하며, 샘플링 전략을 통해 자산의 최소 80%를 해당 지수 종목에 투자합니다.

📘 XBI ETF 자세히 알아보기 →

U.S.equitybiotechnology

규모: $10.0B 약 14조원
운용사: State Street
운용 방식: 패시브 (지수 추종)
상장일: 2006년

Cost Efficiency

Annual Expense Ratio · Category Rank · Long-Term Cost Impact

Low-cost ETF — 0.35% annually

상위 25% within US Equities - Industry Sector. For a ₩100M investment, roughly ₩350,000/year.

Effective Annual Expense Ratio (Net Expense Ratio)

상위 25%

0.35%

My positionTop 25%

Low range Average High range

Actual Cost Simulation by Investment Amount

$100.0M

Annual Expense Ratio

$350K

Save $150K per year vs. category average

Category Median Annual Cost

$500K

Based on expense ratio of 0.50%

10-Year Cumulative Expense Ratio (Long-term simulation assuming 7% annual market growth)

$6.3M

6.6% of returns you could have earned goes to the fund manager due to fees

💡 Because the expense ratio takes a slice of your assets every year, costs compound over 10 years and result in far greater losses than a simple sum (annual fee × 10). The 7% annual return assumption is based on the S&P 500's long-term average.

Defaults shown against $100K baseline portfolio. Adjust the slider to update the amount in real time.

Cheaper alternatives in the same category

State Street Technology Select Sector SPDR ETF

0.08%

-0.27%p annually

XLF

State Street Financial Select Sector SPDR ETF

0.08%

-0.27%p annually

* A lower fee does not necessarily mean a better ETF. Consider the tracked index, liquidity, and tax treatment as well.

Long-Term Performance

1-year · 3-year · 5-year · 10-year returns · vs. benchmark · drawdown defense

Returns slightly below average

하위 25% vs. US Equities - Industry Sector.+53.5%p vs. benchmark (SPY) over 1Y.

ℹ️ The "1Y·3Y·5Y·10Y" periods below represent annualized returns (CAGR) measured backward from today. Example: "3Y +12%" means the investment grew at a compounded 12% per year over the past three years.

If you had invested 10 year(s) ago

$100.0M

Today's value

$271.9M

→

Total gain

+$171.9M

Annualized +10.5%

1 Year

2025.07 ~ 2026.07

Annualized +71.35%

상위 5%

Outperformed the benchmark by 53.5%p annually

My positionTop 5%

Low range Average High range

3 Years

2023.07 ~ 2026.07

Annualized +20.87% Cumulative +76.6%

평균권

Outperformed the benchmark by 1.9%p annually

My positionMid-range

Low range Average High range

5 Years

2021.07 ~ 2026.07

Annualized +3.76% Cumulative +20.3%

하위 25%

Trailed the benchmark by 9.1%p annually

My positionBottom 25%

Low range Average High range

10Y

2016.07 ~ 2026.07

Annualized +10.52% Cumulative +171.9%

평균권

Trailed the benchmark by 4.4%p annually

My positionMid-range

Low range Average High range

10Y Cumulative Total Return Curve

2016-07-28 start, based on a 100M KRW base — read the curve values directly as units of 100M KRW (e.g., 308 → 3.08억 / 308M KRW). Both this ETF and the benchmark are rebased to 100 on the same start date for comparison.

XBI · Price Only XBI · Price + Cumulative Dividends XBI · Dividend Reinvested S&P 500 (SPY)

150

250

350

450

ℹ️ Price Only: Excludes dividends and tracks pure stock price only. Covered-call and high-dividend ETFs often show a flat or declining line on this view, which is meaningful from a "principal preservation" standpoint. Price + Cumulative Dividend: Share count stays the same and received dividends are accumulated as cash. Closely matches your actual account total assets. Reinvested: Dividends are immediately used to buy additional shares (adjClose-based, the industry standard for total return). The wider the gap between the three lines, the easier it is to gauge the effectiveness of the dividend strategy.

Annual Return Comparison

ETF returns vs S&P 500 (SPY) by calendar year

XBI S&P 500 (SPY)

+50%

−50%

+43%

2017

-18%

2018

+31%

2019

+49%

2020

-21%

2021

-28%

2022

+10%

2023

-0%

2024

+34%

2025

+24%

2026 YTD

ℹ️ Returns from January 1 to December 31 of each year. The current year (2026) column is dimmed to indicate YTD (incomplete). If blue is higher than gray, the ETF outperformed the benchmark in that year.

Win rate vs S&P 500 (SPY)

3 / 9Y

Lags behind benchmark (33%)

+ 2026 YTD: Ahead (23.9% vs 8.5%)

2017 ✓

2018 ✗

2019 ✗

2020 ✓

2021 ✗

2022 ✗

2023 ✗

2024 ✗

2025 ✓

2026 ✓ YTD

ℹ️ Number of winning years versus S&P 500 (SPY) within a completed calendar year (1/1–12/31). The current year (YTD) is reported separately.

Downside Capture

⚠️ 113%

Falls more than the benchmark — vulnerable in drawdowns

<85% (Defend) 85~110% (Track) >110% (Lag)

ℹ️ Average % drop of this ETF when S&P 500 (SPY) is −1%. Based on daily returns over the past 3 years (only days where the benchmark is negative).

Risk Profile

Volatility · Beta · Max Drawdown · Sharpe · Drawdown Recovery History

Overall Risk Grade

Moderate Risk

Volatility is around market average. Be prepared for losses of roughly -30% to -40% in major downturns.

Beta (market sensitivity)

평균권

0.83

If the market rises +10% +8.3%

If the market falls -10% -8.3%

My positionMid-range

Low range Average High range

ℹ️ A beta of 1.0 moves in line with the market. Above 1 means it moves more than the market; below 1 means less.

Average daily range (last 1 month)

하위 25%

±2.69%

S&P 500 typically ±1.0~1.3% · Bond funds ±0.3% · Leveraged ETFs ±3% or more

Annual volatility trend (past 10 years)

ℹ️ This ETF's average daily price swing. 1% means "on average, moves about ±1% per day." The rolling curve below shows the annualized volatility (long-term standard measure) over time.

Max Drawdown · Past 10 years

-63.9%

Drawdown duration: 15 months

2021-02-08 → 2022-05-11

Still recovering

2015-07-31 Worst -61% 2026-07-01

ℹ️ Maximum drawdown is the largest peak-to-trough decline in the past. It represents the worst-case loss a long-term investor must psychologically endure.

Sharpe Ratio (Risk-Adjusted Return)

0.08

Weak — Low risk-adjusted returns

ℹ️ Annualized return minus the risk-free rate (3% annualized), divided by annualized volatility. A value above 1.0 is generally considered good risk-adjusted performance.

Estimated Monthly Maximum Loss (VaR 95%)

-13.9%

Historically, monthly losses exceeding this figure occurred only5%of the time.

ℹ️ A statistical estimate meaning "with 95% probability, monthly losses will not exceed this amount." The remaining 5% corresponds to crisis-level events such as financial crises or pandemics.

Dividend Analysis

Yield · Dividend history · After-tax income calculator

Pays dividends, but at a relatively low rate — 0.38% annually

Closer to a blend of growth and dividends.5-year dividend growth rate: +9.6%.

배당수익률

0.38%

주당 배당

$0.57

연간 기준

5년 성장률

9.6%

지급 주기

반기배당

9월 · 12월

📊 총 이력 2007~2025 (46건)

연도별 배당 총액 추이

주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.

$0.43 -36.1%

2015

$0.15 -64.1%

2016

$0.20 +32.0%

2017

$0.20 +0.0%

2018

$0.00 -98.0%

2019

$0.28 +6950.0%

2020

$0.04 -85.8%

2021

$0.02 -57.5%

2023

$0.13 +682.4%

2024

$0.45 +235.3%

2025

$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소

최근 배당 이력 총 46건

아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.

배당락일

주당 금액

지급일

당시 수익률

2025-12-22

$0.407

—

0.36%

2025-09-22

$0.027

—

0.06%

2025-06-23

$0.007

—

0.18%

2025-03-24

$0.005

—

0.16%

2024-12-23

$0.003

—

0.14%

2024-09-23

$0.015

—

0.15%

2024-06-24

$0.115

—

0.14%

2023-12-18

$0.014

—

0.02%

2023-06-20

$0.003

—

0.00%

2021-03-22

$0.040

—

0.22%

2020-12-21

$0.176

—

0.19%

2020-09-21

$0.089

—

0.10%

2020-06-22

$0.017

—

0.02%

2019-12-20

$0.001

—

0.02%

2019-09-20

$0.003

—

0.11%

2018-12-21

$0.012

—

0.31%

2018-09-21

$0.073

—

0.24%

2018-06-15

$0.058

—

0.31%

2018-03-16

$0.059

—

0.28%

2017-12-15

$0.035

—

0.27%

2017-09-15

$0.037

—

0.26%

2017-06-16

$0.110

—

0.31%

2017-03-17

$0.020

—

0.24%

2016-12-16

$0.018

—

0.49%

2016-09-16

$0.031

—

0.52%

2016-06-17

$0.046

—

0.84%

2016-03-18

$0.058

—

0.98%

2015-12-18

$0.149

—

0.85%

2015-09-18

$0.050

—

0.79%

2015-06-19

$0.146

—

0.93%

2015-03-20

$0.082

—

0.96%

2014-12-19

$0.164

—

1.07%

2014-09-19

$0.188

—

1.03%

2014-06-20

$0.205

—

0.73%

2014-03-21

$0.111

—

0.33%

2013-12-20

$0.013

—

0.33%

2013-09-20

$0.029

—

0.29%

2013-06-21

$0.017

—

0.29%

2013-03-15

$0.015

—

0.24%

2012-12-21

$0.066

—

0.22%

2009-12-18

$0.001

—

0.31%

2009-03-20

$0.050

—

1.77%

2008-12-19

$0.002

—

1.31%

2008-06-20

$0.224

—

1.19%

2007-12-21

$0.007

—

0.26%

2007-06-15

$0.046

—

0.26%

* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.

💰 내가 $100K 투자한다면

연간 배당금 (세후) $322

5년 누적 (세후) $2K

* 환율 1 가정, 배당소득세 15% 반영. 5년 누적은 배당 성장률 연 9.6% 가정.

* Qualified dividend middle-bracket approximation. Actual rate varies by total income.

Overall investment appeal

What this ETF fits best — strengths, weaknesses, and target investor profile

Warrants a closer look Several metrics show warning signs. Compare it with similar ETFs before deciding.

🎯 목적별 적합도

내가 이 ETF를 어떤 목적으로 활용할 수 있는지 확인하세요.

🌳

장기 보유

수년 이상 꾸준히 모아갈 때

낮음

💵

배당 인컴

매월·분기 현금흐름이 목적일 때

부적합

⚡

단기 트레이딩

며칠~몇 주 단기 방향성 매매

매우 낮음

🧩

포트폴리오 보조

자산 배분·헤지 용도

낮음

👤

이런 분에게 어울려요

Long-term and recurring investors

✅ 강점

💸Low cost — 0.35% annually

⚠️ 약점·주의사항

📈Long-term returns trail the average
⚠️Volatility is above average
🎯Trails benchmark by -9.1%p annually

Portfolio Composition

What's actually inside — sector weights and top holdings

156개 종목에 넓게 분산

개별 종목 리스크가 분산되어 있어요.

ℹ️ 왜 구성을 봐야 하나요?

ETF의 실제 성과는 담고 있는 종목과 섹터에서 나와요. 이름이 "S&P 500"이라도 기술주 비중이 유난히 높을 수 있고, "배당주 ETF"라도 몇몇 대형주에 쏠려 있을 수 있어요. 라벨보다 실제 구성을 확인하는 게 중요해요.

🔬 집중도 한눈에 보기

총 보유종목

156개

상위 10개 비중

20.4%

최대 단일 종목

8.01%

집중도(HHI)

158

낮음 (분산)

🥧 섹터 비중

Healthcare

94.3%

Financial

0.2%

📋 상위 보유 종목 Top 10 Top 10이 전체의 20.4% 차지

티커 옆의 점 색상 = 섹터 구분 (섹터 차트와 동일 색상)

MYMK State Street Global Advisors

8.01%

APLS Apellis Pharmaceuticals Inc

1.83%

ALKS Alkermes PLC

1.45%

MDGL Madrigal Pharmaceuticals Inc

1.38%

TGTX TG Therapeutics Inc

1.35%

INSM Insmed Inc

1.34%

SRRK Scholar Rock Holding Corp

1.30%

APGE Apogee Therapeutics Inc

1.28%

UTHR United Therapeutics Corp

1.24%

#10

SMMT Summit Therapeutics Inc

1.24%

Category Peers

Category: US Equities - Industry Sector

같은 카테고리 6종 중 AUM 3/6위 · 보수율 4/6위

카테고리: US Equities - Industry Sector

ℹ️ 왜 비교해야 하나요?

같은 카테고리 ETF끼리는 보수율·규모(AUM)·배당률을 비교해 볼 가치가 있어요. 보수율은 낮을수록 장기 수익에 유리하고, AUM이 크면 운용 안정성이 높아요. ▲ 표시는 XBI보다 유리, ▼ 표시는 XBI보다 불리를 뜻해요.

티커	ETF명	보수율	AUM	보유종목	배당률	YTD	1년
XBI	State Street SPDR S&P Biotech ETF	0.35%	$10.0B	157	0.38%	+23.51%	+71.89%
XLV	State Street Health Care Select Sector SPDR ETF	0.08% ▲	$42.5B ▲	63	1.55% ▲	-	+19.72% ▼
VHT	Vanguard Health Care ETF	0.09% ▲	$18.3B ▲	428	1.54% ▲	-	+21.93% ▼
IYH	iShares U.S. Healthcare ETF	0.38% ▼	$3.4B ▼	105	1.17% ▲	-	+19.81% ▼
FHLC	Fidelity MSCI Health Care Index ETF	0.08% ▲	$3.3B ▼	325	1.29% ▲	-	+22.30% ▼
IHI	iShares U.S. Medical Devices ETF	0.38% ▼	$3.0B ▼	52	0.47% ▲	-	-16.38% ▼

AUM 내림차순 정렬 · ▲ XBI보다 유리 · ▼ XBI보다 불리

Leveraged & Covered Call ETFs on the Same Theme

ETFs that approach the same theme with a different strategy

8 ETFs tracking the same theme as XBI using leveraged or covered call strategies (Leverage 5 · Inverse 2 · Covered Call 1)

Not direct derivatives of XBI, but ETFs that cover the same theme via a different strategy.

ℹ️ Which ETFs are included?

Among ETFs whose theme (category or sector) overlaps with XBI, some use special strategies. Leveraged ETFs aim for 2–3× the daily move, Inverse ETFs seek opposite-direction returns, and Covered Call ETFs generate monthly income from option premiums.

⚠️ Caution: Long-Term Holding

Leveraged and inverse ETFs track only the daily return. With high volatility, holding them for longer periods causes cumulative volatility decay—returns diverge further from the underlying index. They are meant for short-term trading.

📈 Leverage 5 ETFs that amplify the same theme by 2-3x (high volatility)